GENESIS: AI-Driven Market Intelligence
TELIX PHARMACEUTICALS - Q1 2026 EARNINGS CALL ANALYSIS & DEEP DIVE
· 1 h 0 min · Temporada 1 Episódio 52
Notas do episódio
A deep dive into Telix Pharmaceuticals — a company operating at the intersection of nuclear medicine, precision oncology, and targeted radiopharmaceuticals.
Telix is building a differentiated position in a rapidly evolving segment of healthcare: the use of targeted radiation to both detect and treat cancer. What makes this space particularly interesting is the combination of diagnostic imaging and therapeutic applications.
At the core of Telix’s current business is its imaging portfolio, led by Illuccix and Gozellix, which are used in the detection of prostate cancer. These products have…
Site: podcasters.spotify.com
